Nutex Health (US:NUTX) Prnewswireยท2025-11-18 23:50Core Insights - Nutex Health Inc. announced restated financial results for Q1 2025, highlighting significant growth in revenue and net income compared to the same period in 2024 [1][2][5] Financial Restatement - The Audit Committee concluded that previously issued financial statements for Q1 2025 required restatement due to non-cash adjustments, resulting in a net increase in liabilities by $19.6 million (4.0%) and a decrease in equity by $19.6 million (7.1%) [2][7] - Net income for Q1 2025 increased by $6.6 million (14.9%) to $21.2 million, with diluted earnings per share rising to $3.33 from $2.56 [2][6] Financial Highlights - Total revenue for Q1 2025 reached $211.8 million, a 214.0% increase from $67.5 million in Q1 2024 [6][8] - EBITDA for Q1 2025 was $51.5 million, up 624.7% from $7.1 million in Q1 2024, while adjusted EBITDA increased to $72.8 million from a loss of $0.4 million [6][8] - Net cash from operating activities was $51.0 million for Q1 2025, reflecting strong operational performance [6][8] Operational Performance - The number of patient visits increased by 20.5% to 48,269 in Q1 2025 compared to 40,068 in Q1 2024, with mature hospitals seeing a 5.3% increase in visits [8] - The company reported a record high gross profit margin of 55.9% and a cash balance of $84.7 million as of March 31, 2025 [5][8] Company Overview - Nutex Health operates 24 micro hospitals and outpatient departments across 11 states, focusing on integrated healthcare delivery [1][19] - The company is structured into two divisions: Hospital Division and Population Health Management Division, providing a range of healthcare services [19][20]